These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice. Brady LS; Herkenham M; Rothman RB; Partilla JS; König M; Zimmer AM; Zimmer A Brain Res Mol Brain Res; 1999 May; 68(1-2):193-7. PubMed ID: 10320798 [TBL] [Abstract][Full Text] [Related]
45. Emotional responses to pleasant and unpleasant music correlate with activity in paralimbic brain regions. Blood AJ; Zatorre RJ; Bermudez P; Evans AC Nat Neurosci; 1999 Apr; 2(4):382-7. PubMed ID: 10204547 [TBL] [Abstract][Full Text] [Related]
46. Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Schrepf A; Harper DE; Harte SE; Wang H; Ichesco E; Hampson JP; Zubieta JK; Clauw DJ; Harris RE Pain; 2016 Oct; 157(10):2217-2225. PubMed ID: 27420606 [TBL] [Abstract][Full Text] [Related]
48. How would you feel versus how do you think she would feel? A neuroimaging study of perspective-taking with social emotions. Ruby P; Decety J J Cogn Neurosci; 2004; 16(6):988-99. PubMed ID: 15298786 [TBL] [Abstract][Full Text] [Related]
49. Feeding Releases Endogenous Opioids in Humans. Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384 [TBL] [Abstract][Full Text] [Related]
50. Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. Crespo-Facorro B; Paradiso S; Andreasen NC; O'Leary DS; Watkins GL; Ponto LL; Hichwa RD JAMA; 2001 Jul; 286(4):427-35. PubMed ID: 11466121 [TBL] [Abstract][Full Text] [Related]
51. Obesity is associated with decreased μ-opioid but unaltered dopamine D2 receptor availability in the brain. Karlsson HK; Tuominen L; Tuulari JJ; Hirvonen J; Parkkola R; Helin S; Salminen P; Nuutila P; Nummenmaa L J Neurosci; 2015 Mar; 35(9):3959-65. PubMed ID: 25740524 [TBL] [Abstract][Full Text] [Related]
52. Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil. Wagner KJ; Sprenger T; Kochs EF; Tölle TR; Valet M; Willoch F Anesthesiology; 2007 Mar; 106(3):548-56. PubMed ID: 17325514 [TBL] [Abstract][Full Text] [Related]
53. A potential cholinergic mechanism of procaine's limbic activation. Benson BE; Carson RE; Kiesewetter DO; Herscovitch P; Eckelman WC; Post RM; Ketter TA Neuropsychopharmacology; 2004 Jul; 29(7):1239-50. PubMed ID: 14997171 [TBL] [Abstract][Full Text] [Related]
54. Placebo effects on human mu-opioid activity during pain. Wager TD; Scott DJ; Zubieta JK Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917 [TBL] [Abstract][Full Text] [Related]
55. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids. Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519 [TBL] [Abstract][Full Text] [Related]
56. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. Smith YR; Stohler CS; Nichols TE; Bueller JA; Koeppe RA; Zubieta JK J Neurosci; 2006 May; 26(21):5777-85. PubMed ID: 16723535 [TBL] [Abstract][Full Text] [Related]